The NK group 2 member D (NKG2D) ligands (NKG2DL), highly expressed in tumor cells, were tested as CAR-T targets, and showed that NKG2D-based CAR-T effectively kill NKG2Dhigh HCC cells [83]. The gene discussed is KLRK1; the disease is hepatocellular carcinoma.